EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Fundamentals of Clinical Pharmacology: Understanding Drug Actions and Ensuring Safety

    Clinical pharmacology offers the interface between the philosophies of pharmacology and its application in the actual sense in patient care Fundamentally it is the science which examines the activities of drugs how drugs communicate with biological systems and how such communications result in treatment outcomes or adverse events Clinical pharmacology principles are needed to make sense of how m...

    Sustainability in Pharma Manufacturing: A Focus on Green Practices

    The pharmaceutical industry is pivotal to global healthcare but its manufacturing processes typically carry a significant environmental burden In recent years there has been an increasing recognition of the importance of sustainability in pharmaceutical manufacturing

    Unlocking Value: Data Science Applications in Pharmacoeconomics

    In the realm of healthcare where every decision has significant financial implications pharmacoeconomics plays a pivotal role It involves the evaluation of the economic impact of pharmaceutical products and services

    From Digital Transformation to Intelligent Pharma: How AI Is Reshaping Pharmaceutical Strategy

    Pharmas digital transformation has solved one problem well access to information Market signals arrive continuously Commercial teams generate customer and channel data medical and scientific functions accumulate new evidence and supply and finance teams produce operational signals that enterprise platforms can now connect across what were once separate systems

    Pharma Email Marketing Europe: Personalized Campaigns for C-Suite Leads

    The pharmaceutical industry is a very competitive industry and to reach the decisionmakers a focused and strategic marketing strategy is necessary Conventional marketing is not often precise enough to reach executives that drive buying alliances and strategic relationships Here the pharma email marketing has come to play as a potent instrument of relationship establishment with the key stakeholder...

    Medical Devices and Pharma: A Symbiotic Relationship for Improved Healthcare

    The healthcare industry is continually evolving driven by technological advancements and innovative approaches to patient care Among the most significant developments is the symbiotic relationship between medical devices

TOP ARTICLES

press releases Read more...

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays

Monod Bio a Seattlebased AIenabled protein design company and SignalChem Biotech Inc a whollyowned subsidiary of Sino Biological Inc SZSE today announced a nonexclusive licensing agreement

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition

Nxera Pharma Co Ltd Nxera or the Company TSE announces that its partner Neurocrine Biosciences Inc Neurocrine has received IND Acceptance from the US Food and Drug Administration

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

Revolution Medicines Inc a global commercialstage oncology company dedicated to discovering developing and delivering innovative medicines for patients with RASaddicted cancers

HepaRegeniX Receives Orphan Drug Designation for Darizmetinib for the Prevention of Post-Hepatectomy Liver Failure

HepaRegeniX GmbH a clinicalstage biotech company advancing novel therapies for acute and chronic liver diseases today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

4basebio and Genezen Expand Collaboration on Synthetic DNA for Viral Vector Manufacturing

basebio PLC a specialist in enzymatically produced cellfree DNA for genetic medicines has expanded its collaboration with viral vector contract development and manufacturing organisation CDMO Genezen

Cronus Pharma Launches FDA-Approved Bioequivalent R

Cronus Pharma LLC has launched Robenacoxib Injection in the US offering an FDAapproved bioequivalent to ONSIOR robenacoxib Injection for veterinary use

Artis BioSolutions Launches mRNA and LNP Manufacturing Centre in Bilbao, Spain

Artis BioSolutions has launched its Genetic Medicines Centre of Excellence in Bilbao Spain expanding its development and manufacturing capabilities for genetic medicines

Lundbeck and EVERSANA Expand Partnership to Advance AI-Powered Commercialisation

Lundbeck a global pharmaceutical company focused on brain health and EVERSANA a provider of commercial services for the life sciences industry have announced a strategic partnership

Cambrex High Point Completes Regulatory Inspections to Support Commercial API Manufacturing

Cambrex a global contract development and manufacturing organisation CDMO has completed PreApproval Inspections PAIs at its High Point North Carolina facility by the US Food and Drug Administration FDA

ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for Hereditary Angioedema

ADARx Pharmaceuticals Inc has received Fast Track Designation from the US Food and Drug Administration FDA for onvuzosiran an investigational small interfering RNA siRNA therapy being developed to prevent attacks of hereditary angioedema HAE